Complexity and clinical significance of drug–drug interactions (DDIs) in oncology: challenging issues in the care of patients regarding cancer-associated thrombosis (CAT)
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1433-7339
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Complexity and clinical significance of drug–drug interactions (DDIs) in oncology: challenging issues in the care of patients regarding cancer-associated thrombosis (CAT) ; volume:30 ; number:10 ; day:6 ; month:8 ; year:2022 ; pages:8559-8573 ; date:10.2022
Supportive care in cancer ; 30, Heft 10 (6.8.2022), 8559-8573, 10.2022
- Creator
-
Tsoukalas, Nikolaos
Brito-Dellan, Norman
Font, Carme
Butler, Taylor
Rojas-Hernandez, Cristhiam M.
Butler, Thomas
Escalante, Carmen
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00520-022-07235-8
- URN
-
urn:nbn:de:101:1-2022121421155492061894
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:27 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Tsoukalas, Nikolaos
- Brito-Dellan, Norman
- Font, Carme
- Butler, Taylor
- Rojas-Hernandez, Cristhiam M.
- Butler, Thomas
- Escalante, Carmen
- SpringerLink (Online service)
Other Objects (12)
Correction to: Complexity and clinical significance of drug–drug interactions (DDIs) in oncology: challenging issues in the care of patients regarding cancer‑associated thrombosis (CAT)
Anti-coagulant Treatment of Cancer-Associated Thrombosis in Frail Patients: Impact of Frailties on the Management of Drug–Drug Interactions
Challenging Situations in the Treatment of Cancer-Associated Thrombosis
A Review of Daclatasvir Drug–Drug Interactions
Drug–Drug Interactions with Direct Oral Anticoagulants
Extracting drug-drug interactions from biomedical texts
Delta-9-Tetrahydrocannabinol and Cannabidiol Drug-Drug Interactions
Case report: Medical cannabis—warfarin drug-drug interaction
Lurasidone drug-drug interaction studies: a comprehensive review
DPDDI: a deep predictor for drug-drug interactions
Pharmacovigilance of Drug–Drug Interactions with Nirmatrelvir/Ritonavir
Evaluating drug-drug interaction information in NDF-RT and DrugBank
Correction to: Complexity and clinical significance of drug–drug interactions (DDIs) in oncology: challenging issues in the care of patients regarding cancer‑associated thrombosis (CAT)
Anti-coagulant Treatment of Cancer-Associated Thrombosis in Frail Patients: Impact of Frailties on the Management of Drug–Drug Interactions
Challenging Situations in the Treatment of Cancer-Associated Thrombosis
A Review of Daclatasvir Drug–Drug Interactions
Drug–Drug Interactions with Direct Oral Anticoagulants
Extracting drug-drug interactions from biomedical texts
Delta-9-Tetrahydrocannabinol and Cannabidiol Drug-Drug Interactions
Case report: Medical cannabis—warfarin drug-drug interaction
Lurasidone drug-drug interaction studies: a comprehensive review
DPDDI: a deep predictor for drug-drug interactions
Pharmacovigilance of Drug–Drug Interactions with Nirmatrelvir/Ritonavir
Evaluating drug-drug interaction information in NDF-RT and DrugBank
Correction to: Complexity and clinical significance of drug–drug interactions (DDIs) in oncology: challenging issues in the care of patients regarding cancer‑associated thrombosis (CAT)
Anti-coagulant Treatment of Cancer-Associated Thrombosis in Frail Patients: Impact of Frailties on the Management of Drug–Drug Interactions
Challenging Situations in the Treatment of Cancer-Associated Thrombosis
A Review of Daclatasvir Drug–Drug Interactions
Drug–Drug Interactions with Direct Oral Anticoagulants
Extracting drug-drug interactions from biomedical texts
Delta-9-Tetrahydrocannabinol and Cannabidiol Drug-Drug Interactions
Case report: Medical cannabis—warfarin drug-drug interaction
Lurasidone drug-drug interaction studies: a comprehensive review
DPDDI: a deep predictor for drug-drug interactions
Pharmacovigilance of Drug–Drug Interactions with Nirmatrelvir/Ritonavir